# US 2026/0092269 A1 · Methods for selecting variant guide rna and prime editing guide rna scaffolds, guide rna and prime editing guide rna compositions and methods of using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0092269 A1
- Document ID: US20260092269A1
- Status: Published application
- Kind: A1
- Application number: 19/347,564
- Filed: 2025-10-01
- Published: 2026-04-02
- Earliest claimed: 2024-10-01
- Applicants: Duke University
- Inventors: Bruce SULLENGER; Telmo Llanga; Jonathan ZHOU
- Web page: https://patentgrep.com/patent/US20260092269A1

## CPC

- C12N 15/1013: {by using magnetic beads}
- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 15/1096: {cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR}
- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- C12N 15/86: Viral vectors
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6869: Methods for sequencing
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N 2750/14143: viral genome or elements thereof as genetic vector
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Methods of generating novel guide nucleic acids, novel guide nucleic acids generated by the methods, mixtures and complexes comprising the novel guide nucleic acids are disclosed.

## Claims

### Claim 1

A composition comprising a gRNA scaffold comprising a sequence selected from the group consisting of SEQ ID NOs: 1-134 or a sequence having at least 98% identity to at least one of SEQ ID NO: 1-134.

### Claim 2 (depends on 1)

The composition of claim 1, further comprising a gRNA target region.

### Claim 3 (depends on 2)

The composition of claim 2, wherein the gRNA target region is about 20 nucleotides in length and is proximate to a protospacer adjacent motif (PAM).

### Claim 4

(canceled)

### Claim 5 (depends on 1)

The composition of claim 1, further comprising a Cas protein capable of forming a ribonucleoprotein complex with the gRNA scaffold.

### Claim 6 (depends on 5)

The composition of claim 5, wherein the Cas protein is a Staphylococcus aureus Cas9 protein or a variant thereof capable of forming a ribonucleoprotein complex with at least one of the gRNA scaffolds in the composition.

### Claim 7

(canceled)

### Claim 8 (depends on 1)

A construct comprising the composition of claim 1, wherein the construct comprises a first polynucleotide encoding a Cas9 protein operably linked to a promoter to allow expression of the Cas9 protein and a second polynucleotide operably linked to a promoter, wherein the second polynucleotide comprises a sequence capable of encoding the gRNA scaffold.

### Claim 9

(canceled)

### Claim 10

(canceled)

### Claim 11 (depends on 1)

A method of using the composition of claim 1 for gene editing in a cell comprising introducing the composition into the cell to allow genetic editing of the cell producing an edited cell and selecting the edited cell comprising an edited target.

### Claim 12

A method of generating a guide nucleic acid (gRNA) capable of binding a Cas protein, the method comprising:
a. generating a RNP complex pool by combining a Cas protein with a gRNA having a conserved target region and a randomized scaffold region;
b. introducing a target DNA bound to or capable of binding to an affinity reagent, wherein the DNA comprises a PAM site and sequence complementary to the conserved target region of the gRNA,
c. mixing the RNP complex with the affinity reagent and target DNA to generate an RNP-DNA-affinity reagent mixture,
d. separating an RNP-DNA-affinity reagent complex from the DNA-affinity reagent mixture, and
e. harvesting the gRNA from the RNP-DNA-affinity reagent complex.

### Claim 13 (depends on 12)

The method of claim 12, wherein the gRNA is capable of directing the Cas protein to perform site-specific cleavage of a targeted double-stranded DNA proximate to a PAM site.

### Claim 14 (depends on 12)

The method of claim 12, further comprising at least one of:
i. sequencing the gRNA,
ii. reverse transcribing and cloning the gRNA into a vector;
iii. reverse transcribing and amplifying the gRNA.

### Claim 15

(canceled)

### Claim 16

(canceled)

### Claim 17 (depends on 12)

The method of claim 12, further comprising repeating steps (a)-(e) multiple rounds.

### Claim 18 (depends on 12)

The method of claim 12, wherein the target DNA is labeled on the 5′ end proximal to the PAM site with the affinity reagent or wherein the target DNA is labeled on the 5′ end distal to the PAM site with the affinity reagent.

### Claim at position 19

-21. (canceled)

### Claim 22

A method of enriching recovery of edited sequences after prime editing comprising:
(a) generating a ribonucleoprotein (RNP)-DNA complex by contacting at least one prime editing guide RNA (pegRNA) with a target DNA and a prime editing protein complex comprising a Cas9 nickase and a reverse transcriptase (RT), wherein the pegRNA comprises a 5′ region and a 3′ region complementary to the target DNA and an intended edited region to be incorporated into the target DNA the reverse transcript;
(b) incubating the RNP-DNA complex to allow the Cas nickase to generate a nick in the target DNA and the RT to incorporate the complement of the intended edit into the nicked strand of the target DNA to generate a single-strand DNA incorporated edit;
(c) introducing a nucleic acid probe sequence complementary to the single-strand DNA incorporated edit to bind to the edited DNA, wherein the probe is labeled or is capable of binding to a label; and
(d) separating the edited DNA by selecting for the label and thus enriching for recovery of edited sequences.

### Claim 23 (depends on 22)

The method of claim 22, wherein the probe further comprises a homopolynucleotide.

### Claim 24 (depends on 23)

The method of claim 23, wherein the homopolynucleotide is a polyadenine or polycytosine.

### Claim at position 23

-28. (canceled)

### Claim 29 (depends on 22)

The method of claim 22, wherein the probe comprises at least one locked nucleic acid.

### Claim 30 (depends on 22)

The method of claim 22, wherein the pegRNA is a pool of pegRNA comprising at least 10 pegRNAs designed to edit the same target DNA and including the intended edited region.

### Claim 31

(canceled)

### Claim 32 (depends on 22)

The method of claim 22, wherein the pegRNA is capable of binding to a modified or engineered Cas protein.

### Claim 33 (depends on 22)

The method of claim 22, wherein the Cas9 protein or modified Cas9 protein is a Streptococcus pyogenes or Staphylococcus aureus Cas9 protein.

### Claim 34

(canceled)

### Claim 35 (depends on 22)

The method of claim 22, further comprising recovering the pegRNA from the separated edited DNA.
